Dow Jones

38,589.16

-0.15%

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
USA
USOTC
Ayala Pharmaceuticals Inc (PK) (ADXS)
Ayala Pharmaceuticals Inc (PK) (ADXS) News

Ayala Pharmaceuticals (PK) (ADXS)

Ayala Pharmaceuticals Inc (PK)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:ADXS

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
06/03/2024	12:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
05/03/2024	21:30	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
05/03/2024	13:16	Edgar (US Regulatory)	Form DEFM14C - Definitive information statement relating to merger or acquisition	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
23/02/2024	21:30	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
20/02/2024	22:22	Edgar (US Regulatory)	Form PREM14C - Preliminary information statements relating to merger or acquisition	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
14/02/2024	21:26	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
12/02/2024	19:16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
12/02/2024	16:58	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
12/02/2024	13:27	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
09/02/2024	22:15	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
06/02/2024	13:51	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
03/01/2024	21:18	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
21/11/2023	14:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
21/11/2023	14:00	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
20/11/2023	14:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
15/11/2023	21:04	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
08/11/2023	21:01	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
03/11/2023	15:46	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
03/11/2023	15:45	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
03/11/2023	15:43	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
02/11/2023	20:05	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
31/10/2023	11:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
31/10/2023	11:05	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
23/10/2023	11:45	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
23/10/2023	11:45	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
23/10/2023	11:43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
23/10/2023	11:43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
20/10/2023	21:31	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
29/09/2023	11:13	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)
29/09/2023	11:10	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	USOTC:ADXS	Ayala Pharmaceuticals Inc (PK)